Boehringer Ingelheim
E_DEPRECATED Error in file »functions_general.php« at line 326: Function utf8_encode() is deprecated
E_DEPRECATED Error in file »functions_general.php« at line 326: Function utf8_encode() is deprecated
E_DEPRECATED Error in file »functions_general.php« at line 186: Function utf8_encode() is deprecated
E_DEPRECATED Error in file »functions_general.php« at line 186: Function utf8_encode() is deprecated
Category
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146 affiliates and a total of more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2014, Boehringer Ingelheim achieved net sales of about 13.3 billion euros. R&D expenditure corresponds to 19.9 per cent of its net sales.
Keywords:
Boehringer Ingelheim News
| Date | News | 2018-07-10 | New production center for Veterinary Public Health | 2018-07-04 | Biologicals_fill_finish_Shanghai | 2018-07-02 | CHMP Positive Opinion | 2018-06-29 | World_Scleroderma_Day_2018 | 2018-06-27 | Atrial Fibrillation Poll | 2018-06-25 | Type 1 Diabetes | 2018-06-22 | New Biologicals Development Center in Germany announced | 2018-06-18 | European Metacam® indication expanded to guinea pigs | 2018-06-01 | realgido study results | 2018-05-23 | Spiolto Respimat enables greater physical activity |
|---|